Amyotrophic lateral sclerosis and Huntington’s disease appear to exhibit impaired Nrf2 signalling, while the evidence for Nrf2 activation in aging is minimal and unclear. The gene discussed is NFE2L2; the disease is juvenile Huntington disease.